Skip to main content
JAZZ logo
JAZZ
(NASDAQ)
Jazz Pharmaceuticals plc
$186.95-- (--)
Loading... - Market loading

Jazz Pharmaceuticals (JAZZ) Stock Price & Financial Analysis

Jazz Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$185.00 - $188.41
52-Week High$198.00
52-Week Low$95.49
Open$186.12
Volume695.87K
Average Volume (3M)695.87K
Market Cap11.40B
Shares Outstanding60.98M
Price to Sales (P/S)2.69
Price to Book (P/B)2.66
EV/EBITDA142.19
Revenue (TTM)4.27B
Net Income (TTM)-356.15M
Free Cash Flow (TTM)1.15B
EPS (TTM)$-5.84
Profit Margin-8.35%
Operating Margin27.47%
Return on Equity (ROE)-8.25%
Debt to Equity1.25
50-Day MA$176.77
200-Day MA$147.06
52-Week Change50.63%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Jazz Pharmaceuticals

What is the current stock price for JAZZ?

As of the latest trading session, JAZZ stock trades at $186.95. The 52-week range is $95.49–$198.00, with a day range of $185.00–$188.41.

What is the P/E ratio for JAZZ?

The P/E ratio (Price-to-Earnings) for JAZZ is shown in the Key Statistics section. This valuation metric helps compare Jazz Pharmaceuticals plc to industry peers.

Does JAZZ pay dividends?

Jazz Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for JAZZ?

Based on 8 analysts, the consensus for JAZZ is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of JAZZ?

Jazz Pharmaceuticals's market capitalization is $11.40B, classifying it as a large-cap company. Jazz Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.